Macrolactams by engineered biosynthesis
    3.
    发明授权
    Macrolactams by engineered biosynthesis 失效
    通过工程化生物合成的新戊酰胺

    公开(公告)号:US07855192B2

    公开(公告)日:2010-12-21

    申请号:US12011068

    申请日:2008-01-23

    CPC分类号: C12P17/10 C07D225/06

    摘要: Macrolactams are made by feeding aromatic amino acids as replacement starter units to a mutant strain of the geldanamycin-producing microorganism Streptomyces hygroscopicus var. geldanus NRRL 3602, wherein the gene cluster encoding enzymes for the biosynthesis of the natural starter unit 3-amino-5-hydroxybenzoic acid has been deleted.

    摘要翻译: 通过将芳香族氨基酸作为替代起始单位加入到产生格尔德霉素的微生物链霉菌吸湿链霉菌变异体的突变菌株中来制备麦芽糖内酰胺。 格尔氏菌NRRL 3602,其中编码天然起始单元3-氨基-5-羟基苯甲酸生物合成酶的基因簇已被缺失。